StockData
Panacea Life Sciences Holdings, Inc. logo

Panacea Life Sciences Holdings, Inc. (PLSH) stock

PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)

Close on Oct 19, 2026Market cap $1.15MP/E –Yield –

Panacea Life Sciences r&d expenses

Research and development expenses are spending on new products and technology.

Panacea Life Sciences's R&D Expenses for the twelve months ending Dec 31, 2020 was $0. For fiscal 2020 it was $0, down 100.0% from the year before. The highest annual figure on record is $369.34K in fiscal 2016.

Annual r&d expenses

PeriodPeriod endValueChange
FY2020Dec 31, 2020$0-100.0%
FY2019Dec 31, 2019$22.10K-92.6%
FY2018Dec 31, 2018$300.00K-15.7%
FY2017Dec 31, 2017$356.08K-3.6%
FY2016Dec 31, 2016$369.34K+377.5%
FY2015Dec 31, 2015$77.34K+32.6%
FY2014Dec 31, 2014$58.32K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2020Dec 31, 2020$0-100.0%
Q3 FY2020Sep 30, 2020$0-100.0%
Q2 FY2020Jun 30, 2020$0-100.0%
Q1 FY2020Mar 31, 2020$0-100.0%
Q3 FY2019Sep 30, 2019$10.00K-86.7%
Q2 FY2019Jun 30, 2019$10.00K-86.7%
Q1 FY2019Mar 31, 2019$15.00K-80.0%
Q4 FY2018Dec 31, 2018$75.00K0.0%
Q3 FY2018Sep 30, 2018$75.00K-13.8%
Q2 FY2018Jun 30, 2018$75.00K-29.2%
Q1 FY2018Mar 31, 2018$75.00K-15.0%
Q4 FY2017Dec 31, 2017$75.00K-50.9%
Q3 FY2017Sep 30, 2017$87.00K-10.5%
Q2 FY2017Jun 30, 2017$105.87K+14.3%
Q1 FY2017Mar 31, 2017$88.21K+229.8%
Q4 FY2016Dec 31, 2016$152.70K–
Q3 FY2016Sep 30, 2016$97.24K–
Q2 FY2016Jun 30, 2016$92.65K–
Q1 FY2016Mar 31, 2016$26.75K–
Q4 FY2015Dec 31, 2015$0–
Q1 FY2015Mar 31, 2015$0–

More Panacea Life Sciences figures

See a number that looks wrong?